| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,459 |
1,251 |
$663.20 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,332 |
2,029 |
$409.04 |
| 82274 |
|
250 |
249 |
$0.00 |
| 80061 |
Lipid panel |
1,880 |
1,873 |
$0.00 |
| 86703 |
|
660 |
655 |
$0.00 |
| 84439 |
|
65 |
65 |
$0.00 |
| 82540 |
|
574 |
569 |
$0.00 |
| 3077F |
|
202 |
182 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
164 |
164 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
30 |
29 |
$0.00 |
| 3078F |
|
598 |
523 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
47 |
44 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
17 |
$0.00 |
| 99442 |
|
154 |
147 |
$0.00 |
| 99443 |
|
275 |
270 |
$0.00 |
| 85027 |
|
860 |
833 |
$0.00 |
| 82043 |
|
574 |
569 |
$0.00 |
| 3079F |
|
162 |
154 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
676 |
673 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
546 |
526 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
803 |
790 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
757 |
749 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,999 |
1,869 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,400 |
2,383 |
$0.00 |
| 90686 |
|
37 |
37 |
$0.00 |
| 3075F |
|
172 |
169 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,621 |
4,210 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
72 |
71 |
$0.00 |
| 1111F |
|
150 |
134 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
164 |
164 |
$0.00 |
| 4450F |
|
57 |
54 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,373 |
1,273 |
$0.00 |
| 86593 |
|
146 |
146 |
$0.00 |
| 3044F |
|
242 |
242 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
291 |
287 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
58 |
57 |
$0.00 |
| 1220F |
|
201 |
196 |
$0.00 |
| 81001 |
|
112 |
110 |
$0.00 |
| 3074F |
|
493 |
430 |
$0.00 |
| 86592 |
|
44 |
44 |
$0.00 |
| 86780 |
|
72 |
72 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
16 |
$0.00 |
| 90656 |
|
20 |
20 |
$0.00 |
| 3080F |
|
16 |
15 |
$0.00 |